writer-selfloop
Writing self-loop for surveys: run the strict section-quality gate, then rewrite only the failing `sections/*.md` files until the report is PASS. **Trigger**: writer self-loop, writing loop, quality gate loop, rewrite failing sections, 自循环, 反复改到 PASS. **Use when**: per-section files exist but C5 is FAIL/BLOCKED (thin sections, missing leads/front matter, citation-scope violations, generator voice). **Skip if**: you are still pre-C2 (NO PROSE), or evidence packs are incomplete (fix C3/C4 first). **Network**: none. **Guardrail**: do not invent facts; only use citation keys present in `citations/ref.bib`; keep citations in-scope per `outline/evidence_bindings.jsonl`; do not add/remove citation keys during rewrites.
Installation
Suivez les instructions du dépôt pour votre agent. Consultez les fichiers et dépendances avant l’installation.
Voir la source ↗GuidesInstructions
Fonctions et usage
Writing self-loop for surveys: run the strict section-quality gate, then rewrite only the failing `sections/*.md` files until the report is PASS. **Trigger**: writer self-loop, writing loop, quality gate loop, rewrite failing sections, 自循环, 反复改到 PASS. **Use when**: per-section files exist but C5 is FAIL/BLOCKED (thin sections, missing leads/front matter, citation-scope violations, generator voice). **Skip if**: you are still pre-C2 (NO PROSE), or evidence packs are incomplete (fix C3/C4 first). **Network**: none. **Guardrail**: do not invent facts; only use citation keys present in `citations/ref.bib`; keep citations in-scope per `outline/evidence_bindings.jsonl`; do not add/remove citation keys during rewrites.
Démarrage rapide
Suivez les instructions du dépôt pour votre agent. Consultez les fichiers et dépendances avant l’installation.
Guides ↗Exemples
Consultez les exemples du dépôt source.
Voir la source ↗Historique source
- Date d’indexation
- 2026-01-20
- Mise à jour de l’index
- 2026-02-07
- Branch
- main
Les dates concernent ce répertoire. Consultez le dépôt pour l’historique du code.
GitHub ↗chat Comments (0)
Sign in to join the discussion and leave a comment.
No comments yet. Be the first to share your thoughts!